Daily Archives: February 12, 2022

Mucosal serotonin reuptake transporter (SERT) expression in IBS is modulated by gut microbiota via mast cell–prostaglandin E2

Posted on February 12, 2022 by Gastroenterology Journal

Increased colonic serotonin (5-HT) level and decreased serotonin reuptake transporter (SERT) expression in irritable bowel syndrome (IBS) may contribute to diarrhea and visceral hypersensitivity. We investigated whether mucosal SERT is modulated by gut… Continue reading →

Posted in News | Comments Off on Mucosal serotonin reuptake transporter (SERT) expression in IBS is modulated by gut microbiota via mast cell–prostaglandin E2

Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives

Posted on February 12, 2022 by Gastroenterology Journal

Therapeutic drug monitoring (TDM) has emerged as a strategy for treatment optimization in inflammatory bowel diseases in order to maximise benefit and to reach more stringent, objective endpoints. Optimal drug concentrations in IBD vary according to tr… Continue reading →

Posted in News | Comments Off on Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives

Fecal signatures of Streptococcus anginosus and Streptococcus constellatus for non-invasive screening and early warning of gastric cancer

Posted on February 12, 2022 by Gastroenterology Journal

Most patients with gastric cancer (GCa) are diagnosed at an advanced stage. We aimed to investigate novel fecal signatures for clinical application in early diagnosis of GCa. Continue reading →

Posted in News | Comments Off on Fecal signatures of Streptococcus anginosus and Streptococcus constellatus for non-invasive screening and early warning of gastric cancer

Fecal signatures of Streptococcus anginosus and Streptococcus constellatus for non-invasive screening and early warning of gastric cancer

Posted on February 12, 2022 by Gastroenterology Journal

Most patients with gastric cancer (GCa) are diagnosed at an advanced stage. We aimed to investigate novel fecal signatures for clinical application in early diagnosis of GCa. Continue reading →

Posted in News | Comments Off on Fecal signatures of Streptococcus anginosus and Streptococcus constellatus for non-invasive screening and early warning of gastric cancer